Neuroendocrine Tumours
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumours.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours [Phase 2]
Phase 2 clinical trial evaluating the combination of 177Lu-DOTATATE and nivolumab in neuroendocrine tumours and neuroendocrine carcinomas.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours [Phase 2]
Phase 2 clinical trial update evaluating efficacy and safety of Lanreotide Autogel for tumor stabilization in progressive neuroendocrine tum…
-
FDA approval · 2018-01-26FDA Approved: LUTATHERA — Original Application (Advanced Accelerator Applications USA, Inc)
The FDA approved LUTATHERA (Lutetium-177 dotatate) from Advanced Accelerator Applications USA, Inc., for adults with somatostatin receptor–p…